Federal agencies recommended that the United States pause use of the Johnson & Johnson COVID-19 vaccine until authorities can gather more information about reports of a rare blood clotting disorder in six people who received the shot.
“We are recommending a pause in the use of this vaccine out of an abundance of caution,” the Food and Drug Administration (FDA) said in a joint statement with the Centers for Disease Control and Prevention (CDC). An independent CDC committee will meet Wednesday to review the cases.
Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the US. Six women developed a type of rare blood clot called cerebral venous sinus thrombosis, which forms in the brain, in combination with low…